Nuvectis Pharma Stock Buy Hold or Sell Recommendation
| NVCT Stock | USD 8.85 0.50 5.99% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Nuvectis Pharma is 'Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Nuvectis Pharma given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Nuvectis Pharma, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Nuvectis Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Nuvectis Stock please use our How to Invest in Nuvectis Pharma guide. Note, we conduct extensive research on individual companies such as Nuvectis and provide practical buy, sell, or hold advice based on investors' constraints. Nuvectis Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Nuvectis |
Execute Nuvectis Pharma Buy or Sell Advice
The Nuvectis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nuvectis Pharma. Macroaxis does not own or have any residual interests in Nuvectis Pharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nuvectis Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Solid | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Excited | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Nuvectis Pharma Trading Alerts and Improvement Suggestions
| Nuvectis Pharma is way too risky over 90 days horizon | |
| Nuvectis Pharma appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Nuvectis Pharma currently holds about 13.57 M in cash with (12.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.93. | |
| Nuvectis Pharma has a poor financial position based on the latest SEC disclosures | |
| Roughly 45.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Nuvectis Pharma to Participate in the 37th Annual Roth Conference |
Nuvectis Pharma Returns Distribution Density
The distribution of Nuvectis Pharma's historical returns is an attempt to chart the uncertainty of Nuvectis Pharma's future price movements. The chart of the probability distribution of Nuvectis Pharma daily returns describes the distribution of returns around its average expected value. We use Nuvectis Pharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nuvectis Pharma returns is essential to provide solid investment advice for Nuvectis Pharma.
| Mean Return | 1.03 | Value At Risk | -5.84 | Potential Upside | 9.96 | Standard Deviation | 5.13 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nuvectis Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Nuvectis Stock Institutional Investors
The Nuvectis Pharma's institutional investors refer to entities that pool money to purchase Nuvectis Pharma's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Trust Co Of Vermont | 2024-09-30 | 0.0 |
Nuvectis Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nuvectis Pharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nuvectis Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nuvectis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.05 | |
β | Beta against Dow Jones | 0.20 | |
σ | Overall volatility | 5.25 | |
Ir | Information ratio | 0.22 |
Nuvectis Pharma Volatility Alert
Nuvectis Pharma shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Nuvectis Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Nuvectis Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Nuvectis Pharma Fundamentals Vs Peers
Comparing Nuvectis Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nuvectis Pharma's direct or indirect competition across all of the common fundamentals between Nuvectis Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nuvectis Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Nuvectis Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Nuvectis Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Nuvectis Pharma to competition |
| Fundamentals | Nuvectis Pharma | Peer Average |
| Return On Equity | -1.73 | -0.31 |
| Return On Asset | -0.66 | -0.14 |
| Current Valuation | 176.79 M | 16.62 B |
| Shares Outstanding | 23.39 M | 571.82 M |
| Shares Owned By Insiders | 45.35 % | 10.09 % |
| Shares Owned By Institutions | 6.92 % | 39.21 % |
| Number Of Shares Shorted | 1.56 M | 4.71 M |
| Price To Book | 20.11 X | 9.51 X |
| EBITDA | (22.9 M) | 3.9 B |
| Net Income | (19 M) | 570.98 M |
| Cash And Equivalents | 13.57 M | 2.7 B |
| Cash Per Share | 0.93 X | 5.01 X |
| Total Debt | 8.89 M | 5.32 B |
| Current Ratio | 5.20 X | 2.16 X |
| Book Value Per Share | 0.50 X | 1.93 K |
| Cash Flow From Operations | (12.25 M) | 971.22 M |
| Short Ratio | 11.14 X | 4.00 X |
| Earnings Per Share | (1.11) X | 3.12 X |
| Target Price | 18.5 | |
| Number Of Employees | 13 | 18.84 K |
| Beta | 0.22 | -0.15 |
| Market Capitalization | 207.01 M | 19.03 B |
| Total Asset | 18.61 M | 29.47 B |
| Retained Earnings | (73.25 M) | 9.33 B |
| Working Capital | 9.71 M | 1.48 B |
| Net Asset | 18.61 M |
Note: Acquisition by Mosseri Marlio Charles of 240000 shares of Nuvectis Pharma at 5.0 subject to Rule 16b-3 [view details]
Nuvectis Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Nuvectis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Nuvectis Pharma Buy or Sell Advice
When is the right time to buy or sell Nuvectis Pharma? Buying financial instruments such as Nuvectis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Nuvectis Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Thematic Idea Now
Healthcare
Companies that provide healthcare goods and services including hospitals, health maintenance organizations, HMOs, or medical aid manufacturers. The Healthcare theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Nuvectis Stock Analysis
When running Nuvectis Pharma's price analysis, check to measure Nuvectis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvectis Pharma is operating at the current time. Most of Nuvectis Pharma's value examination focuses on studying past and present price action to predict the probability of Nuvectis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvectis Pharma's price. Additionally, you may evaluate how the addition of Nuvectis Pharma to your portfolios can decrease your overall portfolio volatility.